首页> 外文OA文献 >Mechanical properties and in vitro evaluation of bioactivity and degradation of dexamethasone-releasing poly-d-l-lactide/nano-hydroxyapatite composite scaffolds
【2h】

Mechanical properties and in vitro evaluation of bioactivity and degradation of dexamethasone-releasing poly-d-l-lactide/nano-hydroxyapatite composite scaffolds

机译:地塞米松聚-d-l-丙交酯/纳米羟基磷灰石复合支架的力学性能及生物活性和降解的体外评价

摘要

The purpose of this study was to fabricate drug-release nano-composite scaffolds and perform in vitro evaluation of their mechanical properties, bioactivity, biodegradability and drug release behaviors. Porous drug-release poly-d-l-lactide (PDLLA) composite scaffolds filled with different amounts of nano-hydroxyapatite (nano-HAp) were prepared by a technique combining polymer coagulation, cold compression moulding, salt leaching and drug coating. Apatite detected on the scaffolds after exposure to a simulated body fluid showed improvement in bioactivity and the apatite formation ability through the addition of the nano-HAp content in the composites. Nano-HAp incorporation and apatite formation made a positive impact on the mechanical properties of the scaffolds; however, plasticization and degradation of PDLLA had a negative impact. The pH-compensation effect of the composite scaffolds can reduce the risk of chronic inflammation complications. The fabrication method in this study can produce scaffolds with controllable structure, appropriate mechanical properties and degradation rates for cancellous bone repair applications.
机译:这项研究的目的是制造药物释放纳米复合支架,并对其机械性能,生物活性,生物降解性和药物释放行为进行体外评估。通过聚合物凝结,冷压成型,盐浸和药物涂层相结合的技术,制备了填充有不同量的纳米羟基磷灰石(nano-HAp)的多孔药物释放聚-d-丙交酯(PDLLA)复合支架。暴露于模拟体液后在支架上检测到的磷灰石通过添加复合物中的纳米HAp含量显示出生物活性和磷灰石形成能力的改善。纳米HAp的掺入和磷灰石的形成对支架的机械性能产生了积极的影响。但是,PDLLA的增塑和降解具有负面影响。复合支架的pH补偿作用可以降低慢性炎症并发症的风险。在这项研究中的制造方法可以生产具有可控的结构,适当的机械性能和降解速率的支架,用于松质骨修复应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号